Some people in Canada who are particularly vulnerable to illness from COVID-19 have a new treatment option. The antibody-based therapy Evusheld previously used to prevent the virus can now also be used as a treatment.
Two new large-scale reports, one published by Statistics Canada and the other in the Canadian Medical Association Journal, are giving a clearer picture of the long-term impacts of COVID-19 infections on Canadians and the health-care system.
OTTAWA — Prime MinisterJustin Trudeau went before cameras to present his government’s emergency response Monday — not to the long-awaited end of federal border and travel restrictions, but to last
Health Canada has distributed enough of the antiviral Paxlovid to treat more than 700,000 people with COVID-19, yet the provinces have given only a fraction of that medication to patients.